Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 301–350 of 18397
Mr. Chen’s resignation was not because of any disagreement between Mr. Chen and the Company on any matter relating to the Company’s operations, policies or practices.
Dr. Imoigele Aisiku, the Company’s co-Chief Executive Officer, was appointed as the sole Chief Executive Officer and the chairman of the board of directors of the Company, effective immediately.
Following Mr. Liu’s resignation, Mr. Yang Li serves as the sole Chief Executive Officer of the Company.
Henry Liu, who currently serves as one of the Company’s Co-Chief Executive Officers, provided notice to the Company of his resignation as Co-Chief Executive Officer, effective June 2, 2026.
who the Company anticipates will be elevated into the CFO role upon Ms. Locklear’s departure (pending final contract).
On June 1, 2026, Ms. Lisa Locklear informed management of Longeveron Inc. (the “Company”) of her decision to step down as Chief Financial Officer, to become effective July 10, 2026.
the Board of Directors of the Company (the “Board”) appointed Mr. Justin Trojanowski as Vice President, Finance, Principal Financial Officer and Corporate Secretary of the Company, in addition to his current role as Corporate Controller, Treasurer and Principal Accounting Officer of the Company.
Mr. Nicholas Maestas notified Tempest Therapeutics, Inc. (the “Company”) of his decision to resign from his position as Chief Financial Officer of the Company and from any and all other positions he holds with the Company, effective as of June 5, 2026.
On May 29, 2026, the Company and the Bank appointed Angela Krezmer (age 40) to succeed Mr. Fazio as Executive Vice President and Chief Financial Officer effective July 1, 2026.
On May 29, 2026, Vincent Fazio notified Seneca Bancorp, Inc. (the “Company”) and its bank subsidiary, Seneca Savings Bank, National Association (the “Bank”), that he intends to retire as the Company’s and the Bank’s Executive Vice President and Chief Financial Officer effective at the close of business on June 30, 2026.
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
On May 29, 2026, Bally’s Management Group, LLC, a subsidiary of Bally’s Corporation, entered into an employment agreement with Cheryl Ash, as its Senior Vice President, Finance and North America, as well as the Chief Financial Officer of Bally’s Chicago.
the Board of Directors (the “Board”) of the Company approved the appointment of Thomas Surran as President and Chief Executive Officer of the Company and as a director of the Company, in each case effective upon consummation of the ADI Spin-Off Transaction (the “Separation Date”).
Mr. Surran will succeed Jay Geldmacher, who will transition to an executive advisor role and will resign from the Board following the appointment of Mr. Surran upon consummation of the ADI Spin-Off Transaction, pursuant to the terms of a previously announced transition arrangement.
On June 1, 2026, Gencor Industries, Inc. (the “Company”) appointed Mr. Raymond Cole as the Company’s Interim Chief Financial Officer.
On May 7, 2026, the Board accepted the resignations of Jeffrey Todd Marshall as Chief Executive Officer, Anita L. Michaels as Chief Operating Officer and Chairman of the Board, and Roman Israel Wood as President, Treasurer and Secretary. The resignations were effective May 27, 2026.
On May 27, 2026, the Board appointed Teresita Rubio as Treasurer and Chairman of the Board, Sanja Pekovic as President and Chief Executive Officer, and Irina Veselinovic as Secretary, effective May 27, 2026.
Effective June 3, 2026, Mr. J. Tobin Turner, age 51, has been designated to serve as the Company’s Principal Executive Officer for SEC reporting purposes.
On June 3, 2026, World Acceptance Corporation (the “Company”) and Janet L. Matricciani agreed that Ms. Matricciani’s role as Interim President and Chief Executive Officer would terminate effective June 3, 2026.
On June 3, 2026, Bala Padmakumar notified the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”) of his voluntary resignation as the Company's Interim Chief Executive Officer, effective immediately.
Effective June 3, 2026, the Board appointed Jason Remillard as the Company's Chief Executive Officer.
On June 3, 2026 , the Board of Directors (the “Board”) of Alight, Inc. (the “Company” or “Alight”) appointed Stephen A. Lasher to serve as the Company’s Chief Financial Officer, effective as of June 15, 2026 (the “Effective Date”).
Mr. Min Qiu, age 43, is appointed Chief Executive Officer of the Company, effective July 1, 2026.
Ms. Na Li, age 49, is appointed Chief Financial Officer of the Company, effective July 1, 2026.
Joel Block, age 42, was appointed Sphere's Chief Executive Officer effective as of the Closing Date
Effective June 8, 2026, Robert J. Hartman, Jr. will cease to serve as Interim Chief Financial Officer and Treasurer of Stoneridge, Inc. (the “Company”) in connection with the appointment of a permanent Chief Financial Officer and Treasurer as described below.
On June 3, 2026, the Board of Directors (the “Board”) of the Company appointed Scott R. Humphrey, age 55, as Chief Financial Officer and Treasurer of the Company, effective June 8, 2026.
On May 28, 2026 (the “Effective Date”), SpringBig Holdings, Inc. (the “Company”) entered into a Separation Agreement (the “Separation Agreement”) with Jaret Christopher and Mr. Christopher’s service with the Company as Chief Executive Officer and a director concluded.
On June 3, 2026, NextDecade Corporation (the “ Company ”) announced the appointment of John Zuklic as the Chief Financial Officer of the Company, effective July 6, 2026.
the Board of Directors (the "Board") of comScore, Inc. (the "Company") appointed Matt McLaughlin as Chief Executive Officer of the Company.
On June 1, 2026, Marshall S. (“Mackie”) McCrea, III, Co-Chief Executive Officer of Energy Transfer LP (the “Partnership”), notified the Partnership of his intention to retire, effective on or before December 31, 2026.
Upon Mr. McCrea’s retirement, Thomas E. Long, the Partnership’s Co-Chief Executive Officer, will assume the role of sole Chief Executive Officer.
Mr. Stutz will assume the role of Interim Chief Executive Officer effective June 30, 2026.
On June 1, 2026, MillerKnoll, Inc. (the “Company”) announced that its Board of Directors (the “Board”) and Andi R. Owen, the Company’s President and Chief Executive Officer, have mutually agreed that Ms. Owen will retire from the Company effective June 30, 2026.
On May 28, 2026, Cadrenal Therapeutics, Inc. (the "Company") and Matthew K. Szot mutually agreed to his transition from the role of Chief Financial Officer, effective May 28, 2026.
Effective immediately after Mr. Szot's termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Principal Accounting Officer, to serve until a permanent Chief Financial Officer is appointed.
Sukhvinder Gill was appointed as Chief Financial Officer, in addition to his existing roles as Chief Operating Officer and Director of the Company
On June 3, 2026, the Company announced that Andrew Del Matto, its Chief Financial Officer, will be retiring effective upon the start of a successor.
Rejji P. Hayes has retired from his positions as CMS Energy and Consumers Energy Company (“Consumers Energy”) executive vice president and chief financial officer, effective June 3, 2026.
Srikanth (Sri) Maddipati, 43, has been appointed to succeed Hayes as CMS Energy and Consumers Energy executive vice president and chief financial officer, effective June 3, 2026.
Lyron Bentovim notified the Board of his resignation as the Chairperson and a member of the Board and all committees of the Board, and from his roles as President and Chief Executive Officer of the Company, in each case effective June 15, 2026.
On June 1, 2026, the Board appointed Tyler Gates as the Company’s President and Chief Executive Officer and as a director on the Board.
on June 1, 2026, the Board appointed Luke A. Hewko as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer, effective upon Mr. Croal’s retirement.
On June 1, 2026, Thomas V. Croal notified GEN Restaurant Group, Inc. (the “Company”) of his decision to retire from his position as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer of the Company, effective at the close of business on June 1, 2026.
On May 27, 2026, the Board of Directors (the “Board”) of biote Corp. (the “Company”) accepted the resignation of Bret Christensen, the Company’s Chief Executive Officer, from his position as Chief Executive Officer of BioTE Medical, LLC (“BioTE”), effective as of June 8, 2026.
Concurrently, the Board appointed Robert Peterson, current Chief Financial Officer and Chief Business Officer of BioTE, as Interim Chief Executive Officer of BioTE to fill the vacancy created by Mr. Christensen’s resignation, and as a director of the Board, each effective June 8, 2026 (the “Effective Date”).
On June 1, 2026, VisionWave IL Ltd. (“VisionWave IL”), a wholly-owned subsidiary of VisionWave Holdings, Inc. (the “Company”), entered into an Employment Agreement with Mr. Einav Eliraz pursuant to which Mr. Eliraz was appointed Chief Financial Officer (“CFO”) of VisionWave IL, effective June 1, 2026.
Kevin Beth, who departed the Company on May 27, 2026.
appointed Todd Heeter to serve as interim Chief Financial Officer and Treasurer of the Company, effective May 28, 2026
the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.